Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 1,056.00
-21.50 (-2.00%)
Aug 14, 2025, 3:30 PM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 167.24 billion as of August 14, 2025. Its market cap has increased by 43.14% in one year.
Market Cap
167.24B
Enterprise Value
183.50B
Revenue
74.04B
Ranking
n/a
PE Ratio
36.34
Stock Price
1,056.00
Market Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 167.24B, an increase of 41,018.88%. That is a compound annual growth rate of 26.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 167.24B | -4.39% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | 134.55B | 57.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,934.43B |
| Divi's Laboratories | 1,627.99B |
| Cipla | 1,263.32B |
| Apollo Hospitals Enterprise | 1,124.61B |
| Mankind Pharma | 1,020.51B |
| Zydus Lifesciences | 994.96B |
| Fortis Healthcare | 714.04B |
| Alkem Laboratories | 644.28B |